Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
Pediatric Acute Leukemia (PedAL) Screening Trial – Developing New Therapies for Relapsed Leukemias
Protocol ID
APAL2020SC
Disease (Sub Disease)
Leukaemia
Diagnosis Stage
Relapsed/refractory
Location
NSW, QLD, VIC, WA, NZ
Sponsor
LLS PedAL Initiative, LLC
Collaborators
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Links
Trial Status
Open
Sites
The Children's Hospital at Westmead
Christchurch Hospital
Royal Children's Hospital
Queensland Children's Hospital
Perth Children's Hospital
Starship Hospital
Christchurch Hospital
Royal Children's Hospital
Queensland Children's Hospital
Perth Children's Hospital
Starship Hospital
Study Type
Observational
Phase
Not applicable
Age Eligibility
up to 22 Years
International registry ID's
NCT04726241
| Study Title | Pediatric Acute Leukemia (PedAL) Screening Trial – Developing New Therapies for Relapsed Leukemias |
|---|---|
| Protocol ID | APAL2020SC |
| Disease (Sub Disease) | Leukaemia |
| Diagnosis Stage | Relapsed/refractory |
| Location | NSW / QLD / VIC / WA / NZ |
| Sponsor | LLS PedAL Initiative, LLC |
| Collaborators | Children's Oncology Group/ National Cancer Institute (NCI)/ |
| Links | https://clinicaltrials.gov/ct2/show/NCT04726241 |
| Trial Status | Open |
| Trial Open Date | 30/11/2021 |
| Sites | The Children's Hospital at Westmead / Christchurch Hospital / Royal Children's Hospital / Queensland Children's Hospital / Perth Children's Hospital/ Starship Hospital |
| Study Type | Observational |
| Phase | Not applicable |
| Age Eligibility | up to 22 Years |
| International registry ID's | NCT04726241 |